The store will not work correctly when cookies are disabled.
N-(6-(3-chlorophenyl)pyridazin-3-yl)pyridine-3-sulfonamide
ID: ALA4750917
PubChem CID: 162651809
Max Phase: Preclinical
Molecular Formula: C15H11ClN4O2S
Molecular Weight: 346.80
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=S(=O)(Nc1ccc(-c2cccc(Cl)c2)nn1)c1cccnc1
Standard InChI: InChI=1S/C15H11ClN4O2S/c16-12-4-1-3-11(9-12)14-6-7-15(19-18-14)20-23(21,22)13-5-2-8-17-10-13/h1-10H,(H,19,20)
Standard InChI Key: YHLGADIBBBXSTK-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
41.9368 -10.1158 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.5323 -9.4101 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
41.1233 -10.1132 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.7037 -9.4224 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.7026 -10.2420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4106 -10.6509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1203 -10.2415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1175 -9.4188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4088 -9.0136 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.9965 -10.6503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2888 -10.2394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5812 -10.6468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5801 -11.4648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2925 -11.8738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9971 -11.4641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8740 -10.2373 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
40.8236 -9.0076 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.2390 -9.0022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.9467 -9.4116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.6524 -9.0010 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.6497 -8.1829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.9355 -7.7772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2328 -8.1901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
5 10 1 0
12 16 1 0
8 17 1 0
17 2 1 0
2 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 346.80 | Molecular Weight (Monoisotopic): 346.0291 | AlogP: 2.99 | #Rotatable Bonds: 4 |
Polar Surface Area: 84.84 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 5.72 | CX Basic pKa: 1.08 | CX LogP: 2.28 | CX LogD: 1.40 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.78 | Np Likeness Score: -2.26 |
References
1. Kimura H,Suda H,Kassai M,Endo M,Deai Y,Yahata M,Miyajima M,Isobe Y. (2021) N-(6-phenylpyridazin-3-yl)benzenesulfonamides as highly potent, brain-permeable, and orally active kynurenine monooxygenase inhibitors., 33 [PMID:33359168] [10.1016/j.bmcl.2020.127753] |